Have you tried multiple therapies like creams, medications, or opioids without finding relief? There is an FDA-approved non-drug therapy available for those with painful DPN who aren't getting relief or have difficult side effects from drugs.

A small implantable device that interrupts pain signals has been proven to provide meaningful long-lasting pain relief.

See how this therapy helped to relieve pain and enabled her to return to every day living. 

Studies have found that spinal cord stimulation (SCS) significantly reduces DPN pain, providing lasting relief, and provides better results for most patients compared to other treatments such as medication.

SCS has been proven to provide meaningful long-lasting pain relief for up to 10 years for moderate-to-severe DPN pain.¹

people with DPN are 17 times more likely to experience significant pain relief ^(3-5)

of patients experienced treatment success after receiving SCS therapy for 1 year^2* 

Answer a few questions to see if the small implantable device may be right for you.

*Success rates in a population of patients treated with SCS in two studies and followed for up to 10 years.
Results may vary. Not everyone responds to SCS in the same way. 

Medication is often not enough to control pain for many who suffer from painful DPN, and taking pain medication can have serious side effects. Learn how a small implantable device can help relieve DPN pain.

Take a short survey to see if this pain-relief therapy may be right for you.

This therapy might be a good fit for individuals who:

Have had DPN pain for at least a year

Experience pain in the legs or feet, such as:

     - Numbness or tingling

     -Shooting, stabbing, burning, or pins and needles

Have not had success managing DPN pain with their current treatment such as creams, medications, and opioids

Have DPN pain that negatively impacts sleep and quality of life

Discussion

Discuss your pain with a therapy expert and connect with a local pain clinic that can provide the therapy.

Survey

Take the survey to understand if you may be a candidate for this therapy.

Consult

Schedule a consult appointment with a physician to see if this therapy may be right for you and learn about the different stimulators. 

Trial

SCS therapy is available to "test drive" for 3-10 days to determine if the small device is a good option.

Begin your journey to pain relief.

Take the next step in your DPN pain journey and answer a few questions to learn if this therapy might be an option for you. 

Scroll down to take the survey. If it seems that this therapy may be right for you, our support team will call you to answer your questions and help you with the next steps!

Not everyone responds to SCS in the same way, and your experience may vary. Risks include infection, lead movement, pain at the implant site, and loss of therapy effectiveness. Please discuss in detail with your doctor. Patients with diabetes may have an increased risk for surgical complications. Talk to your doctor about your ability to undergo surgery. Please check with your insurance company for specific coverage to your health plan.

1. Zuidema X, et al. Long-term evaluation of spinal cord stimulation in patient with painful diabetic polyneuropathy: an eight-to-ten-year prospective cohort study. Neuromodulation 2022;1-7.

2. van Beek M, Geurts JW, Slangen R, et al. Severity of neuropathy is associated with long-term spinal cord stimulation outcome in painful diabetic peripheral neuropathy: Five-year follow-up of a prospective two-center clinical trial. Diabetes Care. 2018;41(1):32–38. doi:10.2337/dc17-0983.

3. Medtronic Pain Therapy Clinical Summary M221494A016 Rev B. United States; 2022.

4. de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: A multicenter randomized clinical trial. Pain. 2014;155(11):2426–2431. doi:10.1016/j.pain.2014.08.031.

5. Slangen R, Schaper NC, Faber CG, et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: A prospective two-center randomized controlled trial. Diabetes Care. 2014;37(11):3016–3024. doi:10.2337/dc14-0684.

© 2025 Medtronic

US-NEU-2500116

Medtronic Privacy Policy  |  83bar Privacy Policy